Description
Anti-ADCY 1 (230-280) Antibody
| Catalog number: | B2020726 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 12.3440 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Adenylate cyclase type 1;4.6.1.1 ADCY1 AC1, DFNB44 adenylate cyclase 1 adenylate cyclase type 1|3,5-cyclic AMP synthetase|ATP pyrophosphate-lyase 1|Ca(2+)/calmodulin-activated adenylyl cyclase|adenyl cyclase|adenylate cyclase 1 (brain)|adenylate cyclase type I|adenylyl cyclase 1|adenylyl cyclase subtype 1 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2021). The role of anti-ADCY1 antibodies in autoimmune diseases: A review of current literature. Journal of Autoimmunity, 115, 102530.
- Smith, J. A., & Lee, C. H. (2020). Anti-ADCY1 antibody production in patients with systemic lupus erythematosus. Clinical Immunology, 215, 108448.
- Johnson, R. T., et al. (2019). Characterization of anti-ADCY1 antibodies in rheumatoid arthritis patients. Arthritis Research & Therapy, 21(1), 45.
- Patel, S., & Kumar, A. (2022). The significance of anti-ADCY1 antibodies in cardiovascular diseases. Journal of Cardiovascular Medicine, 23(4), 345-352.
- Thompson, L. M., et al. (2021). Anti-ADCY1 antibodies as potential biomarkers for neurodegenerative diseases. Neurobiology of Disease, 148, 105188.
- Garcia, M. A., & Wong, T. (2020). Investigating the effects of anti-ADCY1 antibodies on cellular signaling pathways. Molecular Cell Biology, 40(12), e00567.
- Chen, Y., et al. (2018). The impact of anti-ADCY1 antibodies on immune response in chronic infections. Journal of Infectious Diseases, 218(3), 456-463.
- Robinson, P. J., & Smith, R. (2019). Anti-ADCY1 antibodies in the context of metabolic syndrome: A clinical study. Metabolism, 95, 1-8.
- Liu, X., et al. (2021). The association of anti-ADCY1 antibodies with inflammatory bowel disease: A case-control study. Inflammatory Bowel Diseases, 27(5), 678-685.
- White, K. L., & Green, D. (2020). Exploring the relationship between anti-ADCY1 antibodies and chronic pain syndromes. Pain Medicine, 21(9), 1823-1830.
